Samsara Therapeutics
Nancy combines huge experience in neuroscience with automation and assay development, gained at AstraZeneca and previously at Synthace. Prior to her industry experience she worked at the Institute of Neurology and the Division of Medicine in UCL, after a postdoc at RIKEN Brain Science Institute in Japan. She obtained her PhD at the Queensland Brain Institute, University of Queensland, Australia and her graduate studies were in her native Malaysia.
This person is not in any offices
Samsara Therapeutics
Samsara Therapeutics, Inc. is a biopharmaceutical company aiming to discover the first-in-class therapeutics that treat rare genetic and neurodegenerative diseases and extend a healthy lifespan. Samsara's platform is the largest ever pipeline for the identification, chemical optimization, and in vivo validation of compounds that enhance autophagy.